Retired Stamps OL Dan Federkeil says positive drug test due to medical condition

Canadian offensive lineman Dan Federkeil, who retired from pro football in January, has tested positive for a banned substance that he says is related to a medical condition.

The league announced Monday that Federkeil had tested positive for testosterone and faces a two-game suspension if he decides to return to football. The test was conducted during the off-season.

But Federkeil says the testosterone is being used to treat a medical condition and the positive test comes as no surprise.

“I have been dealing with a medical issue for two years but the nature of the condition allowed me to postpone treatment because I fully realized the medically prescribed drug was not compatible with the CFL/CFLPA drug policy. It was only after the 2017 season was over and after I had made the decision to retire that I began the treatment process,” he said in a statement issued shortly after the suspension was announced.

Stampeders president and general manager John Hufnagel backed Federkeil’s version of events.

“The football team was aware of Dan’s situation from the outset and we appreciate him putting his personal comfort on hold so that he could continue to play for us while remaining in compliance with the drug policy,” Hufnagel said. “We thank Dan once more for his contributions during his five seasons with the Stampeders and wish him health and success in the post-football portion of his life.”

Federkeil was selected in the first round of the 2006 CFL draft by the Toronto Argonauts before signing with the NFL’s Indianapolis Colts. He played four seasons in Indianapolis and won a Super Bowl in 2006. He retired after the 2009 NFL season having played in 26 games for Indy. Toronto traded his rights to Calgary in 2013 when Federkeil returned to pro football in the CFL. He lined up at right tackle for the Stamps in 59 regular-season games, four playoff games and three Grey Cups, winning a championship in 2014.

– with files from the Canadian Press